3695 — GMO Research & AI Balance Sheet
0.000.00%
- ¥5bn
- ¥4bn
- ¥5bn
- 97
- 44
- 67
- 82
Annual balance sheet for GMO Research & AI, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 663 | 665 | 767 | 885 | 688 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 728 | 867 | 1,053 | 879 | 860 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,823 | 2,358 | 2,596 | 2,485 | 2,373 |
Net Property, Plant And Equipment | 19.4 | 32.4 | 28.6 | 23 | 15.3 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,232 | 2,800 | 3,072 | 2,994 | 2,996 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 740 | 1,108 | 1,149 | 932 | 874 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 749 | 1,123 | 1,163 | 946 | 896 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,483 | 1,677 | 1,909 | 2,047 | 2,100 |
Total Liabilities & Shareholders' Equity | 2,232 | 2,800 | 3,072 | 2,994 | 2,996 |
Total Common Shares Outstanding |